Skip to main content
Top
Published in: Clinical & Experimental Metastasis 2/2003

01-03-2003

GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice

Authors: Markus Steinbauer, Markus Guba, Grigore Cernaianu, Gudrun Köhl, Michaela Cetto, Leoni A. Kunz-Schughart, Edward K. Geissler, Werner Falk, Karl-Walter Jauch

Published in: Clinical & Experimental Metastasis | Issue 2/2003

Login to get access
Metadata
Title
GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice
Authors
Markus Steinbauer
Markus Guba
Grigore Cernaianu
Gudrun Köhl
Michaela Cetto
Leoni A. Kunz-Schughart
Edward K. Geissler
Werner Falk
Karl-Walter Jauch
Publication date
01-03-2003
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 2/2003
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1022618909921

Other articles of this Issue 2/2003

Clinical & Experimental Metastasis 2/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine